Total planned funding: $774,406,425
Clear active filters
Côte d'Ivoire
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Côte d'Ivoire | $774,406,425 |
Organizational Types
NGO | $255,978,058 |
Private Contractor | $249,254,047 |
Unknown | $74,162,057 |
Own Agency | $72,911,699 |
University | $53,296,142 |
Host Country Government Agency | $29,607,881 |
Implementing Agency | $26,314,810 |
FBO | $7,411,731 |
Other USG Agency | $3,770,000 |
Multi-lateral Agency | $1,700,000 |
Program Areas
Treatment | $269,857,232 |
Care | $147,703,593 |
Prevention | $143,138,738 |
Governance and Systems | $121,312,048 |
Management and Operations | $54,360,798 |
Testing | $38,034,016 |
Budget Codes
HTXD: Treatment: ARV Drugs | $137,746,826 |
HTXS: Treatment: Adult Treatment | $117,943,658 |
HKID: Care: Orphans and Vulnerable Children | $61,167,364 |
HVMS: Management and Operations | $54,360,798 |
HBHC: Care: Adult Care and Support | $50,804,834 |
OHSS: Health Systems Strengthening | $48,004,883 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $40,470,796 |
HVOP: Sexual Prevention: Other Sexual Prevention | $39,999,670 |
HLAB: Laboratory Infrastructure | $39,413,009 |
HVCT: Testing: HIV Testing and Counseling | $38,034,016 |
HVSI: Strategic Information | $33,894,156 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $30,764,768 |
HMBL: Biomedical Prevention: Blood Safety | $22,753,086 |
HVTB: Care: TB/HIV | $22,078,263 |
PDTX: Treatment: Pediatric Treatment | $14,166,748 |
PDCS: Care: Pediatric Care and Support | $13,653,132 |
HMIN: Biomedical Prevention: Injection Safety | $9,128,090 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $22,328 |
Top Partner Programs
Not Available:
$72,356,909
Countries/Regions
USG Aggregated Agencies:
$47,744,892
Countries/Regions
ACONDA:
$31,455,869
Countries/Regions